Understanding aggressive behavior in people with Intermittent Explosive Disorder
Official title: Psychophysiological Correlates of Cognitive Bias Modification in Intermittent Explosive Disorder
Funded at Temple Univ of the Commonwealth · NIH-10677927 · Data updated 2026-11-12
This study is looking at how certain thought patterns might lead to angry outbursts in people with Intermittent Explosive Disorder, and it aims to find new ways to help manage these feelings through special techniques that focus on both the mind and body.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Temple Univ of the Commonwealth NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project start | September 1, 2023 |
| Project end | June 30, 2026 |
| Funding year | 2023 |
| Award (this year) | $35,837 |
| NIH project number | 1F31MH133291-01 |
| Project ID | NIH-10677927 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals aged 21 and older who have been diagnosed with Intermittent Explosive Disorder.
✕Less likely to help
Patients who do not have Intermittent Explosive Disorder or those under 21 years old may not benefit from this research.
What this research studies
This research investigates how cognitive biases, such as attention to threatening information and hostile intent attribution, contribute to aggressive outbursts in individuals with Intermittent Explosive Disorder (IED). By examining the relationship between these cognitive processes and physiological responses, such as autonomic nervous system arousal, the study aims to develop targeted interventions that address both mental and physical aspects of IED. Participants will be involved in a randomized controlled trial to assess the effectiveness of cognitive bias modification techniques. The goal is to create a comprehensive understanding of IED that can lead to better treatment options.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment strategies for individuals suffering from Intermittent Explosive Disorder, potentially reducing aggressive outbursts and enhancing overall mental health.
How similar studies have gone: Previous research has shown promise in using cognitive bias modification techniques for various mental health disorders, suggesting potential success for this approach in treating IED.
Where this research is happening
-
Temple Univ of the Commonwealth
Philadelphia, United States Active
Researchers
- Principal investigator: Ciesinski, Nicole Katherine — Temple Univ of the Commonwealth
- Study coordinator: Ciesinski, Nicole Katherine
Related research
Other NIH-funded projects on the same topics.
-
Complement in the heart’s microenvironment during renewal
This grant explores how immune signals involving the Complement system help heart cells multiply to repair the heart after a heart attack, with the goal of helping patients recover better.
-
Integrating clinical pharmacists into HIV care to reduce cardiovascular disease in people with HIV
A pharmacist-led program in HIV care aims to prevent and manage heart disease risks like high blood pressure, diabetes, and high cholesterol in people living with HIV.
-
NMDAR-TRPM4 signaling and mitochondria in Alzheimer's disease
Scientists are studying how a specific brain cell signaling pathway (NMDAR-TRPM4) relates to nerve cell damage and memory loss in Alzheimer's disease, using patient-derived stem cell models.
-
Understanding how human chaperone networks affect Alzheimer’s- and dementia-related proteins in yeast
Aims to map how human helper proteins (chaperones) interact with dementia-linked proteins using yeast to find which combinations could prevent harmful protein clumps.
-
CRISPR-based Cure for HIV: Targeting reservoirs and boosting immunity
Aims to use CRISPR gene editing to directly cut HIV provirus and strengthen immune responses so people living with HIV can better control the virus even after stopping therapy.
-
Steric-free labeling to map disease-related protein modifications
A scientist-led study uses advanced labeling tricks to identify disease-related protein modifications in human cells.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.